Showing results (1-10 of 1,084) with videos related to
Sort By:
Pageof 109
Endocrinology|May 1, 1993
Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell linesR J Skowronski, D M Peehl, D FeldmanAdvances in Experimental Medicine and Biology|January 1, 1995
Vitamin D and prostate cancerD Feldman, R J Skowronski, D M PeehlEndocrinology|January 1, 1995
Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3R J Skowronski, D M Peehl, D FeldmanCancer Research|February 1, 1994
Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cellsD M Peehl, R J Skowronski, G K Leung, et al.Endocrine-Related Cancer|June 7, 2003
The role of vitamin D and retinoids in controlling prostate cancer progressionD M Peehl, D FeldmanEndocrinology|May 1, 1994
Inhibition of aldosterone synthesis in rat adrenal cells by nicotine and related constituents of tobacco smokeR J Skowronski, D FeldmanUrology|August 15, 2001
Rationale for combination ketoconazole/ vitamin D treatment of prostate cancerD M Peehl, E Seto, D FeldmanEndocrinology|August 1, 1997
1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependentX Y Zhao, L H Ly, D M Peehl, et al.Cancer Research|April 18, 2001
Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibitionJ Y Hsu, D Feldman, J E McNeal, et al.Endocrinology|March 6, 1999
Induction of androgen receptor by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cellsX Y Zhao, L H Ly, D M Peehl, et al.Pageof 109